Fate Therapeutics, Inc. FATE
NASDAQ · United States · Health Technology
$2.32+0.02 (+0.87%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.25 | -0.27 | +6.5% | $2.08M | +55.3% | -5.5%$2.72→$2.57 |
| Q1 2026 | 2026-05-13 | -0.26 | -0.28 | +7.1% | — | — | -15.6%$2.25→$1.90 |
| Q4 2025 | 2026-02-26 | -0.27 | -0.27 | 0.0% | — | — | 0.0%$1.48→$1.48 |
| Q3 2025 | 2025-11-13 | -0.27 | -0.28 | +3.6% | — | — | -7.7%$1.04→$0.96 |
| Q2 2025 | 2025-08-12 | -0.29 | -0.34 | +14.7% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.32 | -0.38 | +15.8% | — | — | — |
| Q4 2024 | 2025-03-05 | -0.44 | -0.42 | -4.8% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.40 | -0.41 | +2.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.